Stratec SE (ETR:SBS – Get Free Report)’s share price rose 1.8% during trading on Tuesday . The company traded as high as €20.20 and last traded at €20.05. Approximately 6,241 shares changed hands during trading, a decline of 0% from the average daily volume of 6,253 shares. The stock had previously closed at €19.70.
Stratec Price Performance
The stock’s 50 day moving average is €18.01 and its two-hundred day moving average is €19.13. The stock has a market capitalization of $240.88 million, a PE ratio of 24.06, a price-to-earnings-growth ratio of 10.43 and a beta of 0.80. The company has a debt-to-equity ratio of 49.40, a current ratio of 4.33 and a quick ratio of 1.65.
About Stratec
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018.
See Also
- Five stocks we like better than Stratec
- These 3 Stocks Have Soared in 2026—Can They Keep Climbing?
- Hasbro’s Earnings Beat Shows Why This Is No Longer Just a Toy Story
- Rambus: Another AI Phoenix Ready to Rise From the Ashes of Correction
- Chips & Clips: Memory Tariffs Rewire Tech Supply Chains
Receive News & Ratings for Stratec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stratec and related companies with MarketBeat.com's FREE daily email newsletter.
